Valneva SE (VALN) Current Leases (2020 - 2026)
Valneva SE (VALN) posted quarterly Current Leases of $3.1 million for Q1 2026, up 1.52% year-on-year from $3.1 million in Q1 2025, and little changed on a QoQ basis from $3.1 million in Q4 2025.
Valneva SE (VALN) Current Leases (2020 - 2026) Analysis & Trends
Valneva SE (VALN) has reported Current Leases for 7 consecutive years, with $3.1 million the latest figure, recorded in Q1 2026.
- Quarterly Current Leases rose 1.52% year-over-year to $3.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.1 million (up 1.52% YoY) and the FY2025 annual result came in at $3.1 million, up 9.21% from the prior year.
- Current Leases was little changed at $3.1 million in Q1 2026 per VALN's latest filing, from $3.1 million in the prior quarter.
- Over the last five years, Current Leases for VALN reached as high as $29.5 million in Q2 2023 and fell as low as $2.9 million in Q4 2024.
- A 5-year average of $9.3 million and a median of $3.1 million in 2026 frame the typical range for Current Leases.
- Annual changes were most pronounced in 2023 — Current Leases jumped 767.82% — and 2024, when it tumbled 89.71%.
- Year by year, Current Leases stood at $28.9 million in 2022, then slumped by 88.67% to $3.3 million in 2023, then dropped by 12.89% to $2.9 million in 2024, then advanced by 9.21% to $3.1 million in 2025, then increased by 0.04% to $3.1 million in 2026.
- According to Business Quant data, Current Leases over the past three periods registered $3.1 million, $3.1 million, and $3.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 531,233.95 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 20.58 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 872,589.03 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 720.00 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 11.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 16.61 Mn |
| 10 | Valneva SE | 803.90 Mn | 680.66 Mn | 5.38 Mn | 3.12 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.12 Mn |
| Dec 31, 2025 | 3.12 Mn |
| Sep 30, 2025 | 3.04 Mn |
| Jun 30, 2025 | 3.01 Mn |
| Mar 31, 2025 | 3.07 Mn |
| Dec 31, 2024 | 2.85 Mn |
| Sep 30, 2024 | 3.02 Mn |
| Jun 30, 2024 | 3.06 Mn |
| Mar 31, 2024 | 3.05 Mn |
| Dec 31, 2023 | 3.28 Mn |
| Sep 30, 2023 | 29.35 Mn |
| Jun 30, 2023 | 29.52 Mn |
| Mar 31, 2023 | 29.34 Mn |
| Dec 31, 2022 | 28.92 Mn |
| Sep 30, 2022 | 3.55 Mn |
| Jun 30, 2022 | 3.40 Mn |
| Mar 31, 2022 | 3.55 Mn |
| Dec 31, 2021 | 3.57 Mn |
| Dec 31, 2020 | 3.07 Mn |